Managing Costs in High Risk Obstetrics: The Value of Technology thatImproves Diagnostic Accuracy

M. Lopes
{"title":"Managing Costs in High Risk Obstetrics: The Value of Technology thatImproves Diagnostic Accuracy","authors":"M. Lopes","doi":"10.4172/2167-0420.1000120","DOIUrl":null,"url":null,"abstract":"In the USA, about 12.8% of babies (more than half a million a year) are born prematurely. The rate of premature birth has increased by 36% since the early 1980’s, [1] and is now responsible for an estimated $26 billion in costs to the American healthcare system annually [2]. Unfortunately, little progress has been made to decrease prevalence in so serious condition. From a managed care perspective, a premature birth constitutes a potential high cost episode of care and high-risk pregnancies constitute a major category of high-cost for payers. In Medicaid, 27% of all inpatient charges and 60% of all hospital procedures covered by Medicaid [3] are related to pregnancy and although only 10% of pregnancies are considered high risk, they account for 57% of total newborn costs [4]. A recent analysis found that overall, 4% of the Medicaid population was responsible for 48% of program spending in 2001 [5]. These high-cost members translate into highly concentrated spending on only a small fraction of the entire population. In this paper we will identify ways in which new technology can improve the diagnostic accuracy of pregnancy-related disorders and assist in managing the costs of high risk obstetrics.","PeriodicalId":17626,"journal":{"name":"Journal of Womens Health Care","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Womens Health Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2167-0420.1000120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

In the USA, about 12.8% of babies (more than half a million a year) are born prematurely. The rate of premature birth has increased by 36% since the early 1980’s, [1] and is now responsible for an estimated $26 billion in costs to the American healthcare system annually [2]. Unfortunately, little progress has been made to decrease prevalence in so serious condition. From a managed care perspective, a premature birth constitutes a potential high cost episode of care and high-risk pregnancies constitute a major category of high-cost for payers. In Medicaid, 27% of all inpatient charges and 60% of all hospital procedures covered by Medicaid [3] are related to pregnancy and although only 10% of pregnancies are considered high risk, they account for 57% of total newborn costs [4]. A recent analysis found that overall, 4% of the Medicaid population was responsible for 48% of program spending in 2001 [5]. These high-cost members translate into highly concentrated spending on only a small fraction of the entire population. In this paper we will identify ways in which new technology can improve the diagnostic accuracy of pregnancy-related disorders and assist in managing the costs of high risk obstetrics.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高风险产科的成本管理:提高诊断准确性的技术价值
在美国,大约12.8%的婴儿(每年超过50万)早产。自20世纪80年代初以来,早产率上升了36%,[1]并且现在每年给美国医疗保健系统造成约260亿美元的成本[2]。不幸的是,在如此严重的情况下,在降低患病率方面进展甚微。从管理式护理的角度来看,早产构成了潜在的高成本护理事件,高风险妊娠构成了支付者高成本的主要类别。在医疗补助中,27%的住院费用和60%的医疗程序[3]与怀孕有关,尽管只有10%的怀孕被认为是高风险的,但它们占新生儿总成本的57%[4]。最近的一项分析发现,2001年总体而言,4%的医疗补助人口承担了48%的项目支出[5]。这些高成本的成员意味着支出高度集中在整个人口的一小部分。在本文中,我们将确定新技术如何提高妊娠相关疾病的诊断准确性,并协助管理高风险产科的成本。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Overview of breast reconstruction options and latest advances and controversies The treatment of acne as a strategy to improve contraceptive adherence in Colombian young women Complementary Alternate Medicine (CAM) therapy against biomarker of oral and breast cancer in women treated with conventional medicine Bacteriocin production by Lactobacillus crispatus vaginal isolates PIH as a complication of pregnancy in the patient with rare disease mastocytosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1